Capula Management »

Agios Pharmaceuticals shares owned by Capula Management

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Capula Management from 13F filings

Historical chart of Capula Management investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Capula Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Capula Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $690k 24k 28.32
2023-03-31 $467k 20k 22.97
2022-12-31 $927k 33k 28.08

More positions owned by Capula Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vaneck Etf Trust Semiconductr Etf (SMH)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Meta Platforms Cl A (META)
Amazon Put Option (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Pioneer Natural Resources (PXD)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Spdr Ser Tr S&p Regl Bkg Call Option (KRE)
Ishares Tr Msci Emg Mkt Etf (EEM)
Select Sector Spdr Tr Financial (XLF)
Capri Holdings SHS (CPRI)

View all positions for Capula Management

Top funds holding Agios Pharmaceuticals

Vanguard Group
Bellevue Group
Dimensional Fund Advisors
Jpmorgan Chase & Co
T. Rowe Price Associates
Arrowpoint Asset Management
Citadel Advisors
Bnp Paribas Investment Partners
Fisher Investments
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Frazier Life Sciences Management
Hudson Bay Capital Management
Charles Schwab Investment Management
Assenagon Asset Management

View all funds holding Agios Pharmaceuticals